You are here

  • Home
  • Archive
  • Volume 4, Issue 1
  • Fusion of the dendritic cell-targeting chemokine MIP3α to melanoma antigen Gp100 in a therapeutic DNA vaccine significantly enhances immunogenicity and survival in a mouse melanoma model

Article info

Article menu

Download PDFPDF

Research Article
Fusion of the dendritic cell-targeting chemokine MIP3α to melanoma antigen Gp100 in a therapeutic DNA vaccine significantly enhances immunogenicity and survival in a mouse melanoma model

Authors

  • James T. Gordy The Department of Molecular Microbiology and ImmunologyJohns Hopkins Bloomberg School of Public Health 615 N. Wolfe Street 21205 Baltimore MD USA PubMed articlesGoogle scholar articles
  • Kun Luo The Department of Molecular Microbiology and ImmunologyJohns Hopkins Bloomberg School of Public Health 615 N. Wolfe Street 21205 Baltimore MD USA PubMed articlesGoogle scholar articles
  • Hong Zhang The Department of Molecular Microbiology and ImmunologyJohns Hopkins Bloomberg School of Public Health 615 N. Wolfe Street 21205 Baltimore MD USA PubMed articlesGoogle scholar articles
  • Arya Biragyn Immunoregulation Section, Laboratory of Molecular Biology and ImmunologyNational Institute on Aging, National Institutes of Health 251 Bayview, Blvd, Suite 100 21224 Baltimore MD USA PubMed articlesGoogle scholar articles
  • Richard B. Markham The Department of Molecular Microbiology and ImmunologyJohns Hopkins Bloomberg School of Public Health 615 N. Wolfe Street 21205 Baltimore MD USA PubMed articlesGoogle scholar articles
  1. ↵a jgordy2{at}jhu.edu
  2. ↵b kluo1{at}jhu.edu
  3. ↵c hzhang{at}jhsph.edu
  4. ↵d biragyna{at}grc.nia.nih.gov
  5. ↵e 410-955-9601 Rmarkha1{at}jhu.edu
View Full Text

Citation

Gordy JT, Luo K, Zhang H, et al
Fusion of the dendritic cell-targeting chemokine MIP3α to melanoma antigen Gp100 in a therapeutic DNA vaccine significantly enhances immunogenicity and survival in a mouse melanoma model
Journal for ImmunoTherapy of Cancer 2016;4:96. doi: 10.1186/s40425-016-0189-y

Publication history

  • Received May 23, 2016
  • Accepted November 7, 2016
  • First published December 20, 2016.
Online issue publication 
February 15, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.